Home › Funds › Bogart Wealth, LLC › VRTX

Bogart Wealth, LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Bogart Wealth, LLC reported holding 27,761 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$14.5M, representing 0.48% of its reported portfolio and ranking #49 among its reported holdings. Bogart Wealth, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)27.76K sh
Reported value held$14.51M
Portfolio Weight0.48%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Bogart Wealth, LLC's VRTX position evolved

Bogart Wealth, LLC first disclosed a stake in VRTX in Q3 2023 at 16,304 shares (US$5.7M). The position peaked in Q3 2026 at 27,761 shares, worth US$14.5M. Across 13 filings, Bogart Wealth, LLC increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 27,761 shares valued at US$14.5M. Notable position changes include a 33% increase in Q2 2025 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.30K $5.67M New
Q4 2023 17.80K $7.24M Add
Q1 2024 18.48K $7.73M Add
Q2 2024 18.99K $8.90M Add
Q3 2024 19.23K $8.94M Add
Q4 2024 22.26K $8.96M Add
Q1 2025 19.17K $9.29M Reduce
Q2 2025 25.41K $11.31M Add
Q3 2025 26.15K $10.24M Add
Q4 2025 27.18K $12.32M Add
Q1 2026 27.20K $12.14M Hold
Q2 2026 27.70K $13.76M Add
Q3 2026 27.76K $14.51M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Bogart Wealth, LLC held VRTX?

Bogart Wealth, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Bogart Wealth, LLC's current position in VRTX?

As of Q3 2026, Bogart Wealth, LLC holds 27.76K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $14.51M, representing 0.48% of its reported portfolio and ranking #49.

Has Bogart Wealth, LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Bogart Wealth, LLC held unchanged its position in VRTX. The position peaked in Q3 2026 at 27.76K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.